COMBINED THERAPY FOR STAGE III-IV HEAD AND NECK-CANCER - PRELIMINARY-RESULTS

被引:5
|
作者
KRASNOW, SH
COHEN, MH
JOHNSTONEARLY, A
CITRON, ML
FOSSIECK, BE
MAUK, CM
YENSON, A
BANDA, FP
LUNZER, S
DEFRIES, HO
机构
[1] VET ADM MED CTR,DEPT SURG,WASHINGTON,DC 20422
[2] VET ADM MED CTR,DEPT RADIOTHERAPY,WASHINGTON,DC 20422
[3] GEORGETOWN UNIV,MED CTR,DEPT OTOLARYNGOL,WASHINGTON,DC 20057
关键词
D O I
10.1200/JCO.1984.2.7.804
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
下载
收藏
页码:804 / 810
页数:7
相关论文
共 50 条
  • [1] ONCOGENES IN HEAD AND NECK-CANCER - PRELIMINARY-RESULTS
    VOLLING, P
    JUNGEHULSING, M
    STENNERT, E
    ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 1987, 244 (05): : 316 - 317
  • [2] ONCOGENES IN HEAD AND NECK-CANCER - PRELIMINARY-RESULTS
    VOLLING, P
    JUNGEHULSING, M
    TESCH, H
    STENNERT, E
    LARYNGOLOGIE RHINOLOGIE OTOLOGIE VEREINIGT MIT MONATSSCHRIFT FUR OHRENHEILKUNDE, 1988, 67 (04): : 160 - 164
  • [3] PRELIMINARY-RESULTS OF COMBINED CHEMOTHERAPY AND RADIATION-THERAPY IN ADVANCED (STAGES III-IV) SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    ROBERT, F
    MUNIZ, F
    MEDINA, R
    TORO, L
    RIVERACINTRON, F
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 475 - 475
  • [4] RANDOMIZED MISONIDAZOLE TRIAL IN RADIOTHERAPY OF ADVANCED HEAD AND NECK-CANCER - PRELIMINARY-RESULTS
    BRUNIN, F
    BATAINI, JP
    ASSELAIN, B
    JAULERRY, C
    BRUGERE, J
    JOURNAL EUROPEEN DE RADIOTHERAPIE, 1983, 4 (04): : 181 - 188
  • [5] INDUCTION CHEMOTHERAPY IN ADVANCED HEAD AND NECK-CANCER - PRELIMINARY-RESULTS OF A RANDOMIZED STUDY
    BRUNIN, F
    RODRIGUEZ, J
    JAULERRY, C
    JOUVE, M
    PONTVERT, D
    POINT, D
    MOSSERI, V
    POUILLART, P
    ASSELAIN, B
    BRUGERE, J
    BATAINI, JP
    ACTA ONCOLOGICA, 1989, 28 (01) : 61 - 65
  • [6] PRELIMINARY-RESULTS IN ADVANCED HEAD AND NECK-CANCER WITH RADIOTHERAPY BY MULTIPLE FRACTIONS A DAY
    GONZALEZ, DG
    BREUR, K
    SCHUEREN, EVD
    CLINICAL RADIOLOGY, 1980, 31 (04) : 417 - 421
  • [7] Can Stage III-IV Head and Neck Cancer Patients Be Treated with Unilateral Radiotherapy?
    Hu, K.
    Kumar, M.
    Sura, S.
    Culliney, B.
    Tran, T.
    Jacobson, A.
    Perksy, M.
    Urken, M.
    Costantino, P.
    Harrison, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S486 - S487
  • [8] Concurrent Definitive Immunoradiotherapy for Patients with Stage III-IV Head and Neck Cancer and Cisplatin Contraindication
    Weiss, Jared
    Sheth, Siddharth
    Deal, Allision M.
    Olson, Juneko E. Grilley
    Patel, Samip
    Hackman, Trevor G.
    Blumberg, Jeffrey M.
    Galloway, Thomas J.
    Patel, Shetal
    Zanation, Adam M.
    Shen, Colette J.
    Hayes, D. Neil
    Hilliard, Christopher
    Mehra, Ranee
    McKinnon, Karen P.
    Wang, Hsing-Hui
    Weissler, Mark Christian
    Bauman, Jessica R.
    Chera, Bhishamjit S.
    Vincent, Benjamin G.
    CLINICAL CANCER RESEARCH, 2020, 26 (16) : 4260 - 4267
  • [9] COMBINED MODALITY THERAPY FOR ADVANCED HEAD AND NECK-CANCER
    WEAVER, A
    LOH, JJK
    VANDENBERG, H
    POWERS, W
    FLEMING, S
    MATHOG, R
    ALSARRAF, M
    AMERICAN JOURNAL OF SURGERY, 1980, 140 (04): : 549 - 552
  • [10] COMBINED-MODALITY THERAPY OF HEAD AND NECK-CANCER
    STUPP, R
    WEICHSELBAUM, RR
    VOKES, EE
    SEMINARS IN ONCOLOGY, 1994, 21 (03) : 349 - 358